The Genomic Atlas of Breast Cancer — the non-coding theme

Update News

  • GABC update 2020.06.15
  • GABC update 2019.03.20
  • GABC online 2018.08.09
  • Data collection 2018.04.09

About Us

  • Steven Xi Chen:
    steven.chen@miami.edu
  • Yunpeng Zhang:
    YXZ1418@med.miami.edu
  • Peng Wang:
    wpgqy@163.com
  • Shangwei Ning:
    ningsw@ems.hrbmu.edu.cn
  • Xia Li:
    lixia@hrbmu.edu.cn

Detail


Chr chr16
start 86565145
end 86567761
lncRNA name FOXC2-AS1
entrez id 103752587
hgnc id HGNC:50665
ensg id ENSG00000260944
refseq id NR_125795
methods qPCR, Western blot etc.
regulated up-regulated
function description Cyclin D1 Cyclin D2, and Cyclin D3 were all partly positively modulated by FOXC2-AS1 in BC. FOXC2-AS1 may serve as a promising prognostic biomarker and therapeutic target for BC patients. FOXC2-AS1 significantly suppressed the proliferation ability and flow cytometric analysis illustrated the influence of FOXC2-AS1 on cell cycle and apoptosis rate.
pubmed id 29562954
year 2018
title Long non-coding RNA FOXC2-AS1 predicts poor survival in breast cancer patients and promotes cell proliferation
drug X
circulating X
survival V

CopyRight © University of Miami, USA; Harbin Medical University, China